Sunflower Therapeutics

Sunflower Therapeutics

Private
Medford, MassachusettsHealthcare & Life Scienceshttps://sunflowertx.com

Last Round

Grant

Sep 4, 2025

Total Funding Raised

$14.36M

Company Overview

Sunflower Therapeutics is a biotechnology company that provides next-generation, automated, and fully-integrated protein manufacturing solutions to reduce the time and cost of developing and manufacturing biologics.

Sector

Healthcare & Life Sciences

Verticals

Biotech Equipment, Biotechnology, Smart Manufacturing, Drug Discovery

Business Model

B2B

Customer Profile

Hardware Sales, Hardware + Subscription, Government Contracts, Services & Consulting

AI Layer

Non-AI

Keywords

protein manufacturingautomated bioprocessingperfusion bioreactorcontinuous biomanufacturingbenchtop bioreactorbiomanufacturing platformsingle-use bioreactordistributed biomanufacturingyeast expression systembioprocessing softwarevaccine developmentbioprocess consumablessynthetic biologyCRO servicescontract research organizationfood tech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Sunflower Therapeutics Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Sunflower Therapeutics Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
GrantSep 4, 2025
SAFEDec 3, 2024
GrantJan 18, 2023
VC RoundAug 17, 2021

Key People

Founding team and executive leadership

Kerry Love

Founder, CEO President

Founding Team

Tom Heer

Chief Financial Officer

Executive Team

Sunflower Therapeutics Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Feb 12, 2026

    Partnered with MATSUBO Corporation for Japanese market expansion.

  • Jan 26, 2026

    Added CESCO Custom Equipment Solutions Co. as a customer.

Sunflower Therapeutics Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Sunflower Therapeutics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Sunflower Therapeutics's valuation, stock price, and market status.

Firmographic Details

HeadquartersMedford, Massachusetts
Employee Range20
Year Founded2018
Last FundingSep 4, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.